{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:07:51Z","timestamp":1791205671320,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T00:00:00Z","timestamp":1430697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126003","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T14:16:15Z","timestamp":1430748975000},"page":"e0126003","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice"],"prefix":"10.1371","volume":"10","author":[{"given":"Kanako","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Iemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Seino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"JJ Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pbiomolbio.2011.07.010","article-title":"Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and beta cell preservation","volume":"107","author":"D Yabe","year":"2011","journal-title":"Prog Biophys Mol Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.2337\/db13-0822","article-title":"Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls","volume":"62","author":"DJ Drucker","year":"2013","journal-title":"Diabetes"},{"key":"ref4","first-page":"E981","article-title":"Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans","volume":"273","author":"MA Nauck","year":"1997","journal-title":"Am J Physiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"A Flint","year":"1998","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diacare.17.9.1039","article-title":"Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM","volume":"17","author":"MK Gutniak","year":"1994","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.beem.2009.03.008","article-title":"Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)-preclinical and clinical results","volume":"23","author":"S Madsbad","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrd1828","article-title":"Exenatide","volume":"4","author":"MB Davidson","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/jm9909645","article-title":"Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration","volume":"43","author":"LB Knudsen","year":"2000","journal-title":"J Med Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/jc.2005-1093","article-title":"Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes","volume":"90","author":"F Fehse","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/dc08-1797","article-title":"One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial","volume":"32","author":"MC Bunck","year":"2009","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1464-5491.2007.02333.x","article-title":"Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus","volume":"25","author":"T Vilsboll","year":"2008","journal-title":"Diabet Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1463-1326.2009.01075.x","article-title":"The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1\u20135 studies","volume":"11","author":"L Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"ME Doyle","year":"2007","journal-title":"Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature02520","article-title":"Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation","volume":"429","author":"Y Dor","year":"2004","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2220\/biomedres.32.167","article-title":"Pancreatic beta-cells are generated by neogenesis from non-beta-cells after birth","volume":"32","author":"K Nakamura","year":"2011","journal-title":"Biomed Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan- and streptozotocin-induced diabetes","volume":"51","author":"S Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(96)90013-6","article-title":"Oxidative damage to DNA in diabetes mellitus","volume":"347","author":"P Dandona","year":"1996","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-213X-1-4","article-title":"Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus","volume":"1","author":"S Srinivas","year":"2001","journal-title":"BMC Dev Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00125-011-2069-9","article-title":"The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes","volume":"54","author":"M Shimoda","year":"2011","journal-title":"Diabetologia"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrg841","article-title":"Pancreatic organogenesis\u2014developmental mechanisms and implications for therapy","volume":"3","author":"H Edlund","year":"2002","journal-title":"Nat Rev Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrendo.2013.157","article-title":"The role of FOXO1 in beta-cell failure and type 2 diabetes mellitus","volume":"9","author":"T Kitamura","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"ref23","first-page":"S26","article-title":"Self-replication is not the only mechanism of maintenance of pancreatic beta cell mass after birth","volume":"54","author":"K Minami","year":"2011","journal-title":"Diabetologia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"42351","DOI":"10.1074\/jbc.R400019200","article-title":"Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes","volume":"279","author":"RP Robertson","year":"2004","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.bjp.0705397","article-title":"GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics","volume":"140","author":"J Sturis","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"G Xu","year":"1999","journal-title":"Diabetes"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","article-title":"Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas","volume":"49","author":"DA Stoffers","year":"2000","journal-title":"Diabetes"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1210\/endo.141.12.7806","article-title":"Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats","volume":"141","author":"R Perfetti","year":"2000","journal-title":"Endocrinology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.52.3.741","article-title":"Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats","volume":"52","author":"JA Pospisilik","year":"2003","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00125-007-0737-6","article-title":"Continuous stimulation of human glucagon-like peptide-1 (7\u201336) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes","volume":"50","author":"J Zhang","year":"2007","journal-title":"Diabetologia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1254\/jphs.09178FP","article-title":"Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats","volume":"111","author":"DY Kwon","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.diabres.2010.10.012","article-title":"A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing beta-cell replication and neogenesis","volume":"91","author":"JM Cho","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.08.003","article-title":"The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions","volume":"364","author":"M Bensellam","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00273856","article-title":"Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes","volume":"28","author":"RH Unger","year":"1985","journal-title":"Diabetologia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/diacare.13.6.610","article-title":"Glucose toxicity","volume":"13","author":"L Rossetti","year":"1990","journal-title":"Diabetes Care"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF00400200","article-title":"Acute and chronic effects of hyperglycaemia on glucose metabolism","volume":"33","author":"H Yki-Jarvinen","year":"1990","journal-title":"Diabetologia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.2337\/dc14-0893","article-title":"Liraglutide and the preservation of pancreatic beta-cell function in early type 2 diabetes: the LIBRA trial","volume":"37","author":"R Retnakaran","year":"2014","journal-title":"Diabetes Care"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2008.03.001","article-title":"Weighing up beta-cell mass in mice and humans: self-renewal, progenitors or stem cells?","volume":"288","author":"NA Hanley","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db10-0084","article-title":"Beta-cell growth and regeneration: replication is only part of the story","volume":"59","author":"S Bonner-Weir","year":"2010","journal-title":"Diabetes"},{"issue":"Pt 3","key":"ref40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1042\/bj3200855","article-title":"Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction","volume":"320","author":"H Kaneto","year":"1996","journal-title":"Biochem J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2337\/diabetes.48.4.927","article-title":"Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes","volume":"48","author":"Y Ihara","year":"1999","journal-title":"Diabetes"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s125-002-8248-z","article-title":"Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients","volume":"45","author":"H Sakuraba","year":"2002","journal-title":"Diabetologia"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1172\/JCI65390","article-title":"Inactivation of specific beta cell transcription factors in type 2 diabetes","volume":"123","author":"S Guo","year":"2013","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2337\/db10-0021","article-title":"Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner","volume":"60","author":"E Mukai","year":"2011","journal-title":"Diabetes"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T23:34:51Z","timestamp":1651880091000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126003"}},"subtitle":[],"editor":[{"given":"Angel","family":"Nadal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,4]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126003","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,4]]}}}